Vectura Group PLC Company Profile (LON:VEC)

About Vectura Group PLC

Vectura Group PLC logoVectura Group plc is a product development company. The Company focuses on the development of pharmaceutical therapies for the treatment of airways-related diseases (airways diseases). The Company has eight products marketed by its partners and a portfolio of drugs in clinical development, a number of which have been licensed to pharmaceutical companies. Its portfolio comprises partnered and licensed marketed products, as well as branded and generic investigational drugs. It has various products in the pipeline, which include VR588, VR942, VR475, VR465, VR096, VR647, VR179, VR736, VR876, NVA237, QVA149, VR315, VR506 and VR632. Its marketed products include Ultibro Breezhaler, Seebri Breezhaler, AirFluSal Forspiro, ADVATE and Adept. Its licensed products include Anoro Ellipta, Relvar Ellipta/Breo Ellipta and Incruse Ellipta. It also has a range of technology platforms, which include formulation technologies, such as PowderHale and ParticleMAX, and device technology, such as GyroHaler.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: VEC
  • CUSIP:
Key Metrics:
  • Previous Close: $1.84
  • 50 Day Moving Average: $139.02
  • 200 Day Moving Average: $155.46
  • 52-Week Range: GBX 122.90 - GBX 200.10
  • Trailing P/E Ratio: 115.42
  • P/E Growth: 0.00
  • Market Cap: $568.71M
  • Outstanding Shares: 410,618,000
Additional Links:

Analyst Ratings

Consensus Ratings for Vectura Group PLC (LON:VEC) (?)
Ratings Breakdown: 8 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: GBX 222.25

Analysts' Ratings History for Vectura Group PLC (LON:VEC)
Show:
DateFirmActionRatingPrice TargetDetails
9/19/2016Numis Securities LtdBoost Price TargetBuyGBX 246 -> GBX 252View Rating Details
9/5/2016Peel HuntReiterated RatingBuyGBX 200View Rating Details
8/30/2016Stifel NicolausReiterated RatingBuyGBX 242View Rating Details
8/30/2016FinnCapReiterated RatingBuyGBX 225View Rating Details
7/28/2016Citigroup Inc.Reiterated RatingBuyGBX 215View Rating Details
7/28/2016JPMorgan Chase & Co.Reiterated RatingOverweightGBX 230View Rating Details
3/1/2016Royal Bank Of CanadaLower Price TargetOutperformGBX 210 -> GBX 205View Rating Details
2/10/2016N+1 SingerReiterated RatingBuyGBX 209View Rating Details
7/21/2015Canaccord GenuityReiterated RatingBuyGBX 222View Rating Details
6/26/2015Barclays PLCReiterated RatingOverweightGBX 180 -> GBX 180View Rating Details
5/15/2015InvestecReiterated RatingHoldGBX 160 -> GBX 192View Rating Details
3/18/2015CRT CapitalDowngradeBuy -> Fair ValueGBX 32 -> GBX 30View Rating Details
1/27/2015Oriel Securities LtdReiterated RatingBuyGBX 207View Rating Details
11/18/2014Shore CapitalReiterated RatingBuyView Rating Details
(Data available from 10/1/2014 forward)

Earnings

Earnings History for Vectura Group PLC (LON:VEC)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Vectura Group PLC (LON:VEC)
Current Year EPS Consensus Estimate: $3.20 EPS

Dividends

Dividend History for Vectura Group PLC (LON:VEC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Vectura Group PLC (LON:VEC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/30/2016Andrew DerodraInsiderBuy30,000GBX 138£41,400
9/27/2016Trevor PhillipsInsiderSell240,841GBX 139£334,768.99
9/26/2016Bruno AngeliciInsiderBuy80,000GBX 143£114,400
7/7/2016Derodra,AndrewInsiderSell263,364GBX 152£400,313.28
6/17/2016Derodra,AndrewInsiderSell419,661GBX 154£646,277.94
6/13/2016Derodra,AndrewInsiderSell279,774GBX 157£439,245.18
7/7/2015Oakley,Andrew J.InsiderBuy1,000GBX 180£1,800
1/15/2015Trevor PhillipsInsiderSell171,777GBX 144.50£248,217.77
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Vectura Group PLC (LON:VEC)
DateHeadline
morningstar.co.uk logoDIRECTOR DEALINGS: Vectura Finance Boss Ups Interest (LON:VEC)
www.morningstar.co.uk - September 30 at 7:11 PM
News IconAtlantic Healthcare appoints Karl Keegan as Chief Financial Officer (LON:VEC)
www.pharmiweb.com - September 29 at 7:37 AM
stockmarketwire.com logoDirector Deals - Vectura Group PLC (VEC) (LON:VEC)
www.stockmarketwire.com - September 28 at 7:46 AM
morningstar.co.uk logoDIRECTOR DEALINGS: Vectura Chairman Buys 80,000 Shares (LON:VEC)
www.morningstar.co.uk - September 27 at 7:53 PM
News IconAnalysts At Numis Reiterated Vectura Group PLC (LON:VEC) As Buy (LON:VEC)
diariocatolico.net - September 19 at 7:37 AM
News IconConsilium Strategic Communications appointed by Vectura Group plc as international financial PR and IR advisor - PharmiWeb.com (press release) (LON:VEC)
www.pharmiweb.com - September 17 at 7:20 PM
News IconConsilium Strategic Communications appointed by Vectura Group plc as international financial PR and IR advisor (LON:VEC)
www.pharmiweb.com - September 16 at 11:36 AM
News IconWhat's Propelling Vectura Group PLC to Increase So Much? - Chester News (LON:VEC)
www.chesterindependent.com - September 15 at 8:02 PM
News IconVectura Group PLC's (VEC) Buy Rating Reiterated at Numis ... - NewsDen (LON:VEC)
newsden.net - September 12 at 7:52 AM
finance.yahoo.com logoDrugmaker Vectura raises revenue outlook on strong trading (LON:VEC)
finance.yahoo.com - September 8 at 11:51 AM
proactiveinvestors.co.uk logoThis unfancied drug stock has the potential to soar (LON:VEC)
www.proactiveinvestors.co.uk - September 8 at 11:51 AM
proactiveinvestors.co.uk logoThis unfancied drug stock has the potential to soar - Proactive Investors UK (LON:VEC)
www.proactiveinvestors.co.uk - September 7 at 8:02 PM
reuters.com logoUK Stocks-Factors to watch on Sept. 7 - Reuters (LON:VEC)
www.reuters.com - September 7 at 11:49 AM
News IconDrugmaker Vectura raises revenue outlook on strong trading - Daily Mail (LON:VEC)
www.dailymail.co.uk - September 7 at 11:49 AM
News IconVectura Group Plc Pipeline Review, Market Demand, Market Price, and Forecast 2016 - 2020 - Medgadget (blog) (LON:VEC)
www.medgadget.com - September 7 at 11:49 AM
money.aol.co.uk logoWhy Vectura group plc and GlaxoSmithKline plc could be the perfect combination - AOL Money UK (LON:VEC)
money.aol.co.uk - September 7 at 11:49 AM
News IconNew findings confirm Ultibro® Breezhaler® consistently more effective than Seretide®* in reducing COPD flare-ups across different patient groups (LON:VEC)
www.pharmiweb.com - September 6 at 8:01 PM
morningstar.co.uk logoVectura Analysis Finds Ultibro Breezhaler More Effective Than Seretide (LON:VEC)
www.morningstar.co.uk - September 6 at 8:01 PM
rttnews.com logoVectura: Study Confirms Ultibro Breezhaler More Effective Than Seretide (LON:VEC)
www.rttnews.com - September 6 at 8:01 PM
News IconVectura Group Plc Pipeline Review, Market Demand, Market Price, and Forecast 2016 – 2020 (LON:VEC)
www.medgadget.com - September 6 at 8:01 PM
News IconNew findings confirm Ultibro® Breezhaler® consistently more effective than Seretide®* in reducing COPD flare-ups ... - PharmiWeb.com (press release) (LON:VEC)
www.pharmiweb.com - September 6 at 7:20 AM
nasdaq.com logoVectura: Study Confirms Ultibro Breezhaler More Effective Than ... - Nasdaq (LON:VEC)
www.nasdaq.com - September 5 at 7:20 AM
publicnow.com logoProduct Update - Ultibro® Breezhaler® (LON:VEC)
www.publicnow.com - September 5 at 7:20 AM
reuters.com logoFitch Rates DBSH's Perpetual Capital Securities 'BBB(EXP)' - Reuters (LON:VEC)
in.reuters.com - August 31 at 8:01 AM
finance.yahoo.com logoAirFluSal® Forspiro® showed superiority at 12 months over Seretide® Diskus® in persistence to treatment - Yahoo Finance (LON:VEC)
finance.yahoo.com - August 31 at 8:01 AM
News IconVectura's asthma therapy misses primary endpoint in final stage trial - Business Insider (LON:VEC)
www.businessinsider.com - August 31 at 8:01 AM
publicnow.com logoProduct Update - AirFluSal® Forspiro® (LON:VEC)
www.publicnow.com - August 31 at 8:01 AM
publicnow.com logoAirFluSal® Forspiro® showed superiority at 12 months over Seretide® Diskus® in persistence to treatment (LON:VEC)
www.publicnow.com - August 31 at 8:01 AM
directorstalkinterviews.com logoVectura Group PLC 78.7% Potential Upside Indicated by finnCap - DirectorsTalk Interviews (LON:VEC)
www.directorstalkinterviews.com - August 30 at 7:50 PM
reuters.com logoBRIEF-Hulic Reit to buy properties for 8.6 bln yen; plans 8.6 bln yen loan - Reuters (LON:VEC)
www.reuters.com - August 30 at 11:25 AM
reuters.com logoVectura's therapy misses primary goal in late stage lung disease trial - Reuters (LON:VEC)
www.reuters.com - August 30 at 11:25 AM
openpr.com logoMarket Size of Drug Delivery Technology, Forecast Report 2016-2026 (LON:VEC)
www.openpr.com - August 26 at 10:57 AM
iii.co.uk logoVECTURA GROUP (LON:VEC)
www.iii.co.uk - August 24 at 11:07 AM
News IconSix takeaways from GSK's first half, from Advair to equity (LON:VEC)
www.investorschronicle.co.uk - August 19 at 7:56 PM
News IconDrug Delivery Technology Market Segments and Key Trends 2016-2026 (LON:VEC)
reports.pr-inside.com - August 17 at 11:02 AM
morningstar.co.uk logoVectura Gets USD8 Million Milestone Payment From Pacira (LON:VEC)
www.morningstar.co.uk - August 5 at 11:11 AM
4-traders.com logoVectura : US$8 million Exparel® sales milestone from Pacira triggered (LON:VEC)
www.4-traders.com - August 5 at 11:11 AM
breakingfinancenews.com logoVectura Group PLC (LON:VEC) price target maintained at 200GBX as issued in a report today by Peel Hunt - Breaking Finance News (LON:VEC)
breakingfinancenews.com - August 1 at 7:53 PM
ftsenews.co.uk logoStifel Nicolaus Gives Vectura Group PLC Price Target With Potential 62.96% Upside - FTSE News (LON:VEC)
www.ftsenews.co.uk - August 1 at 7:49 AM
breakingfinancenews.com logoVectura Group PLC (LON:VEC) price target maintained at 242GBX as issued in a report today by Stifel (LON:VEC)
breakingfinancenews.com - July 29 at 11:09 AM
breakingfinancenews.com logoA statement released today by Numis about Vectura Group PLC(LON:VEC) ups the target price to 246GBX (LON:VEC)
breakingfinancenews.com - July 28 at 8:34 PM
openpr.com logoMarket Intelligence Report Drug Delivery Technology, 2016-2026 (LON:VEC)
www.openpr.com - July 28 at 11:29 AM
streetinsider.com logoForm 8-K SAFEGUARD SCIENTIFICS For: Jul 28 (LON:VEC)
www.streetinsider.com - July 28 at 11:29 AM
finance.yahoo.com logoSafeguard Scientifics Announces Second Quarter 2016 Financial Results (LON:VEC)
finance.yahoo.com - July 28 at 11:29 AM
4-traders.com logoVectura : initiates legal proceedings against GSK relating to option-to-licence patent agreement and confirms 2016 revenue guidance (LON:VEC)
www.4-traders.com - July 28 at 11:29 AM
breakingfinancenews.com logoVectura Group (LON:VEC) target price bumped up to 215GBX as announced today by Citigroup (LON:VEC)
breakingfinancenews.com - July 28 at 11:29 AM
4-traders.com logoVectura : initiates legal proceedings against GSK (LON:VEC)
www.4-traders.com - July 27 at 8:33 PM
ftsenews.co.uk logoPeel Hunt reiterated Vectura Group PLC (LON:VEC) as 'Buy' With 200 PT - FTSE News (LON:VEC)
www.ftsenews.co.uk - July 20 at 10:58 AM
breakingfinancenews.com logoVectura Group PLC (LON:VEC) target price held steady at 200GBX as announced today by Peel Hunt (LON:VEC)
breakingfinancenews.com - July 19 at 8:16 PM
fiscalstandard.com logoVectura Group PLC (LON:VEC) Receives Buy Rating From Peel Hunt Analysts - Fiscal Standard (LON:VEC)
www.fiscalstandard.com - July 19 at 9:01 AM

Social


Last Updated on 10/1/2016 by MarketBeat.com Staff